Literature DB >> 15294889

Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.

C J Munday1, G M Whitehead, N J Todd, M Campbell, P M Hawkey.   

Abstract

OBJECTIVES: This study was conducted to detect the presence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae within the faecal flora of both community- and hospital-based patients in York and to characterize the bla(TEM), bla(SHV) and bla(CTX-M) genes present in these isolates.
METHODS: One thousand faeces samples were collected and screened at York Hospital during October-December 2003. Ninety-five non-duplicate Enterobacteriaceae isolates resistant to third-generation cephalosporins were recovered; 22 isolates were selected for further study on the basis of a positive double disc diffusion test for ESBL production. Antibiotic susceptibility testing was performed to a range of antibiotics. The TEM, SHV and CTX-M genes were detected by PCR and the DNA sequenced.
RESULTS: The distribution of ESBL-positive isolates from the hospital and community was 1.4:1. These included nine Escherichia coli, seven Enterobacter cloacae, four Citrobacter freundii and a single isolate each of Klebsiella spp. and Salmonella spp. A total of 17 isolates contained bla(CTX-M) (five bla(CTX-M-15), three bla(CTX-M-14) and nine bla(CTX-M-9)). ISEcp1 was present in isolates expressing CTX-M-14 and -15, but was absent upstream of In60-associated bla(CTX-M-9). E. coli isolates also contained either a bla(TEM-1) or bla(TEM-2), whereas six of the E. cloacae carried bla(SHV-12) and the Klebsiella spp. bla(SHV-36) in addition to bla(CTX-M-9). The single Salmonella spp. carried bla(SHV-12).
CONCLUSIONS: The overall prevalence of ESBL in isolates of Enterobacteriaceae from York was 1.9%. ESBL-producing isolates were found in both the community and hospital, with the CTX-M type most common. This is also the first report of an ESBL-producing Salmonella in the UK.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294889     DOI: 10.1093/jac/dkh397

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpC.

Authors:  Shelley C Rankin; Jean M Whichard; Kevin Joyce; Lynn Stephens; Kathleen O'shea; Helen Aceto; Donald S Munro; Charles E Benson
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Detection of five novel CTX-M-type extended spectrum beta-lactamases with one to three CTX-M-14 point mutations in isolates from Hefei, Anhui province, China.

Authors:  Hui Li; Jia Bin Li
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  First report of extended-spectrum-beta-lactamase-producing Salmonella enterica isolates in Ireland.

Authors:  Dearbhaile Morris; Mary Whelan; Geraldine Corbett-Feeney; Martin Cormican; Peter Hawkey; Xu Li; Geraldine Doran
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Zoo animals as reservoirs of gram-negative bacteria harboring integrons and antimicrobial resistance genes.

Authors:  Ashraf M Ahmed; Yusuke Motoi; Maiko Sato; Akito Maruyama; Hitoshi Watanabe; Yukio Fukumoto; Tadashi Shimamoto
Journal:  Appl Environ Microbiol       Date:  2007-08-24       Impact factor: 4.792

5.  Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.

Authors:  Corinne Arpin; Véronique Dubois; Jeanne Maugein; Jacqueline Jullin; Brigitte Dutilh; Jean-Philippe Brochet; Gilberte Larribet; Isabelle Fischer; Claudine Quentin
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

6.  SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.

Authors:  Dóra Szabó; Robert A Bonomo; Fernanda Silveira; A William Pasculle; Carla Baxter; Peter K Linden; Andrea M Hujer; Kristine M Hujer; Kathleen Deeley; David L Paterson
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

7.  Antimicrobial resistance gene distribution: a socioeconomic and sociocultural perspective.

Authors:  Kayode K Ojo; Amy R Sapkota; Tokunbo B Ojo; Paul S Pottinger
Journal:  GMS Krankenhhyg Interdiszip       Date:  2008-09-03

Review 8.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

9.  Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.

Authors:  Ståle Tofteland; Bjørg Haldorsen; Kristin H Dahl; Gunnar S Simonsen; Martin Steinbakk; Timothy R Walsh; Arnfinn Sundsfjord
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

10.  Screening of clinical, food, water and animal isolates of Escherichia coli for the presence of blaCTX-M extended spectrum beta-lactamase (ESBL) antibiotic resistance gene loci.

Authors:  John E Moore; Miyuki Watabe; B Cherie Millar; Anne Loughrey; Mark McCalmont; Colin E Goldsmith; J C Neville Heaney; Tom Buckley; Claire Egan; David A McDowell; M Ann S McMahon; James S G Dooley; Jiru Xu; Paul J Rooney
Journal:  Ulster Med J       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.